Form 8-K · Current report
Veeva Systems 8-K, filed Aug 20, 2026
- Filed
- CIK
- 0001393052
- Accession no.
- 0001213900-26-092096
Summary
Veeva Systems appointed Dan Rizzo as EVP, Sales, Consulting, and Services effective October 2, 2026, succeeding Thomas D. Schwenger, who resigned effective the same date to become CEO at a long-standing Veeva partner.
Key points
- Veeva announced the appointment on August 20, 2026, and disclosed it in an 8-K filed August 21, 2026.
- Dan Rizzo's appointment as EVP, Sales, Consulting, and Services takes effect October 2, 2026.
- Thomas D. Schwenger, with Veeva since September 2019 and most recently President and Chief Customer Officer, informed Veeva of his resignation on August 18, 2026.
- Schwenger is departing to assume a CEO role at a long-standing Veeva partner.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 20, 2026, Veeva Systems Inc. (“Veeva”) announced the appointment of Dan Rizzo to serve as EVP, Sales, Consulting, and Services, effective October 2, 2026. Mr. Rizzo succeeds Thomas D. Schwenger, who has been with Veeva since September 2019, most recently serving as President and Chief Customer Officer. Mr. Schwenger informed Veeva of his decision to resign on August 18, 2026 and his resignation is effective October 2, 2026. Mr. Schwenger is departing to assume a CEO role at a long-standing Veeva partner. Veeva thanks Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.